BREZTRI (budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT
- RxCUI
- 2741711
- RxNorm name
- BREZTRI (budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT
- Display name
- BREZTRI (budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT
- Full name
- BREZTRI (budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BREZTRI | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | 715433dc-cb2b-43ea-b6df-c5b4177adc6c | 2026-04-27 | Warnings, Adverse reactions | 2741711 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 715433dc-cb2b-43ea-b6df-c5b4177adc6c | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations [PSN] · 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.018 MG/ACTUAT Metered Dose Inhaler [Breztri] [SBD] · BREZTRI (budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT) Metered Dose Inhaler, 120 ACTUAT [SY] | 3 | 7 | These highlights do not include all the information needed to use BREZTRI AEROSPHERE safely and effectively. See full prescribing information for BREZTRI AEROSPHERE. BREZTRI AEROSPHERE ® (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2020 | 20260427 |